caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1922086669

Carlos FrancoMD

Hematology-OncologyAtlanta, GAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Carlos Franco's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 18 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NORTHSIDE HOSPITAL, INC.4022,711
Elisabeth Gaines
Physician Assistant · Douglasville, GA
111326
Laboratory Corporation Of America Holdings
Clinical Laboratory · Birmingham, AL
73257
BADNIN, MARTHA71159
Pradeep Jolly
Hematology-Oncology · Atlanta, GA
3886
NORTHSIDE HOSPITAL, INC.37186
SOLSTAS LAB PARTNERS GROUP LLC31132
SALAWU, KAFILAT2752
COBB HOSPITAL, INC1837
Sreekanth Vemuri
Diagnostic Radiology · Atlanta, GA
1757
Hector Malave
Cardiology · Atlanta, GA
1556
Milan Mehta
Interventional Radiology · Atlanta, GA
1433
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
111
Unique beneficiaries
—
Total services
133
Distinct HCPCS
4
Medicare payment
$6K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 236 Hematology-Oncology providers in GA — bottom quintile (cohort median 1,046).
PRESCRIBING · PART D · 2024
Total Rx claims
119
Beneficiaries
—
Total drug cost
$632K
Distinct drugs
6
Brand share
56.3%
Top prescribed drugs
Hydroxyurea41 claims
Lenalidomide20 claims
Zanubrutinib19 claims
Rivaroxaban15 claims
Apixaban13 claims
QUALITY · MIPS · 2024
Final MIPS score
71.2
Quality
69.2
Cost
51.4
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
-0.46%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
22
By payment type
Food and Beverage$1K